Thoma Bravo to buy Imprivata for about $544 mln

Thoma Bravo has agreed to acquire healthcare IT security company Imprivata for $19.25 per share or about $544 million. Barclays is providing financial advice to Imprivata on the transaction.

13 July 2016•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles